An in-depth look to KOREAN DRUG CO., LTD. operating, investing, and financing activities

014570 free cash flow for Q3 24 is 2.12 B KRW. For 2023, 014570 free cash flow was -7.81 B KRW and operating cash flow was -2 B KRW.